Η πανδημία συνδέεται με προκλήσεις σε πολλαπλά επίπεδα τα οποία περιλαμβάνουν και τους τομείς δραστηριοτήτων των οργανισμών στους οποίους δραστηριοποιούμαστε ως ΚΕΦΕΑ. Η πανδημία μας έχει επηρεάσει όλους αναπόφευκτα τόσο σε προσωπικό όσο και σε επαγγελματικό επίπεδο...
KEFEA president Kyriakos Mikellis expresses concerns about the second phase of GESΥ Διάβασε το άρθρο
Έξι μήνες μετά την εφαρμογή του ΓεΣΥ. Πόσο καλά τα πήγαμε, ποια τα προβλήματα με τα φάρμακα και τι γίνεται με τις ελλείψεις; Ο Οργανισμός Ασφάλισης Υγείας (ΟΑΥ) και οι εκπρόσωποι του Παγκύπριου Σύνδεσμου Παρασκευαστών Γενε-ρικών Φαρμάκων, της Κυπριακής Ένωσης...
The basic criteria for the system’s success *By Kyriakos Mikellis The provision of healthcare services to Cypriot citizens through the implementation of a functional, efficient and sustainable health system is something that should have happened many years ago. The...
* By Kyriakos Mikellis In most European countries, unlike Cyprus, policies on pharmaceuticals give patients access to the treatment their doctors consider the most appropriate. Pharmaceuticals and pharmaceutical care are usually the responsibility of three independent...
*Joanna Kozakou In recent years there has been a growing interest in the nature of the pharmaceutical industry’s relationships with healthcare professionals and healthcare organizations, particularly because patients and the public at large want to be sure that...
By Joanna Kozakou Issues directly relevant to Cyprus were recently discussed at the “Sustainable Health Systems for Inclusive Growth in Europe” conference, organised under the auspices of the Lithuanian Presidency in Vilnius. Representatives of all Member States,...
*By Joanna Kozakou States are under unprecedented pressure to achieve the correct balance between universal access to high quality Health services and adhering to budgetary constraints. As the European Union’s Commissioner for Health and Consumer Policy, Tonio Borg,...
*by Jacqueline Anastassiades Cyprus is at the start of a very difficult era for its economy, with a multitude of negative consequences on a number of aspects of everyday life. The state, but also the private sector, is trying to put the economy back on a course of...
*By Petros Mavrogenis We have recently been observing the difficulties and challenges faced by many European states. Cutting costs is imperative. Today, more than ever, we must not view costs as mere expenditures but more as an investment, which will bring long term...
Did you know that it takes on average 12 years for a new medicine to get from the lab to the shelves of your Pharmacy? Did you know that only 5 in every 5.000 compounds that enter the preclinical testing phase actually make it to human testing? Did you know that only...
*by Jacqueline Anastassiades Innovation in the pharmaceutical sector is a characteristic of medical progress in general and has contributed dramatically to increasing population survival or improving disease management. Innovation is present in all sectors of economic...
